semaglutide adolescent obesity trial 2022 Half of children given 'skinny jab' no longer clinically obese, study finds | GLP-1 Agonists in Adolescent Obesity:

By 60, you may be producing less than half the growth hormone you did at 25

As a chemist who has spent much of my career at the interface of analytical science and manufacturing, I see this next chapter of GLP-1s primarily as a manufacturing story

Doctors may still prescribe it off-label for weight management in certain cases, but this is less common

Chronic condition cycle Patients with chronic gut conditions, recurring joint issues, or ongoing tissue inflammation often run two to three consecutive cycles with rest periods between each

For blue cross weight loss medication coverage, the first practical step is to explain that formulary and employer-plan rules can vary inside the same insurer